In this study, we showed that melatonin treatment reduced the tumor growth in a xenograft breast cancer model, and consistent with its reduction, melatonin was able to increase the protein expression of cleaved caspase-3, which is the main inducer of apoptosis. Here, CASP3 is linked to breast cancer.